Search for "cucurbit[8]uril" in Full Text gives 13 result(s) in Beilstein Journal of Organic Chemistry.
Beilstein J. Org. Chem. 2025, 21, 179–188, doi:10.3762/bjoc.21.10
Graphical Abstract
Scheme 1: a) Chemical structures of H-bonded macrocycles H1, H2, and guest G1, and schematic representation o...
Figure 1: ESIMS spectrum of an equimolar mixture of G1 and H1 in CHCl3/CH3CN (1:1, v/v), including calculated...
Figure 2: Stacked 1H NMR spectra (CDCl3/CD3CN 1:1, v/v, 400 MHz, 298 K) of G1 upon addition of different equi...
Figure 3: Single-crystal X-ray structure of the complex H2 ⊃ G1. a) Dimeric structure formed by cyclo[6]arami...
Figure 4: Stacked 1H NMR spectra (CDCl3/CD3CN 1:1, v/v, 400 MHz, 298 K) of G2 upon addition of different equi...
Figure 5: TEM images of a solution of H1, G2, and Zn(ClO4)2 at different concentrations (CHCl3/CH3CN 1:1, v/v...
Figure 6: Stacked 1H NMR spectra (CDCl3/CD3CN 1:1, v/v, 400 MHz, 298 K) of G2 and Zn2+ upon addition of diffe...
Figure 7: Specific viscosity of the linear supramolecular polymer in CHCl3/CH3CN (1:1, v/v, 298 K) at variabl...
Figure 8: Variable-concentration 1H NMR spectra of the supramolecular polymer: (a) 2.0 mM, (b) 4.0 mM, (c) 6....
Beilstein J. Org. Chem. 2023, 19, 873–880, doi:10.3762/bjoc.19.64
Graphical Abstract
Figure 1: a) Chemical structure of pseudorotaxanes 1; and (b) single-crystal X-ray structure of rotaxane 1a (R...
Figure 2: (a) Chemical structure of polyrotaxane 2; and (b) cartoon representation of the light-triggered deg...
Figure 3: a) Chemical structures of rotaxanes (E)-3 and (Z)-3; b) stick representation of the solid structure...
Figure 4: Stick representations of the solid structures of: (a) U-CB[8]-MPyVB showing an interlocked ligand c...
Beilstein J. Org. Chem. 2023, 19, 864–872, doi:10.3762/bjoc.19.63
Graphical Abstract
Figure 1: Supramolecular assembly of TMeQ[6] and 1,2-bis(4-pyridyl)ethene (G).
Figure 2: (a) UV–vis titration of G (3.0 × 10−5 mol·L−1, pH 6.5) in aqueous solution with the increase of TMe...
Figure 3: (a) Fluorescence spectra (U = 550 V, pH 6.5) of G (3.0 × 10−5 mol·L−1) in aqueous solution with inc...
Figure 4: (a) Crystal structure of complex 1; (b) and (c) the binding mode of G with TMeQ[6]; (d) the supramo...
Figure 5: (a) Fluorescence response of G (3.0 × 10−5 mol·L−1) to metal cations in aqueous solution; (b) fluor...
Figure 6: Influence of coexisting ions on Hg2+ detection by G@TMeQ[6].
Figure 7: (a) Fluorescence titration curve (U = 500 V, pH 6.5) of probe G@TMeQ[6] (3.0 × 10−5 mol·L−1) to Hg2+...
Figure 8: (A) Titration 1H NMR spectra (400 MHz) obtained for TMeQ[6] with (a) 0.00, (b) 0.50, (c) 1.00 and (...
Beilstein J. Org. Chem. 2022, 18, 225–231, doi:10.3762/bjoc.18.26
Graphical Abstract
Scheme 1: Classical amine purification.
Scheme 2: Principle of out-of equilibrium machinery using TCA (a) and our application to amines purification ...
Scheme 3: Application of the TCA purification from a crude reaction mixture.
Beilstein J. Org. Chem. 2021, 17, 2832–2839, doi:10.3762/bjoc.17.194
Graphical Abstract
Figure 1: The structures of chloramphenicol (A) and cucurbit[n]urils (B).
Figure 2: (A) CPE and Q[8] structural model diagram, (B) interaction between CPE and Q[8], (C) CPE@Q[8] stack...
Figure 3: UV–vis absorption spectra of CPE with Q[8] in aqueous solution (A) or hydrochloric acid solution (C...
Figure 4: ITC data obtained for the binding of Q[8] with CPE in an aqueous solution at 25 °C.
Figure 5: 1H NMR spectra of CPE, CPE@Q[8] and Q[8] (VD2O/VDCl = 3:2).
Figure 6: IR spectra recorded for Q[8] (a), CPE (b), a physical mixture of Q[8] and CPE (c), and the CPE@Q[8]...
Figure 7: UV absorption intensity of CPE and CPE@Q[8] changes with time in the artificial gastrointestinal ju...
Figure 8: Release curve of CPE and CPE@Q[8] in artificial gastrointestinal juice (pH 1.2, pH 6.8).
Beilstein J. Org. Chem. 2020, 16, 2971–2982, doi:10.3762/bjoc.16.247
Graphical Abstract
Figure 1: Three different type of peptide-based fluorescent probes and their interaction with nucleic acids a...
Figure 2: A) Molecular structure of peptidic probe 1, Inset: HeLa cells incubated with peptide 1 (50 μM), sho...
Figure 3: A) Molecular structure of probe 2; B) fluorescence emission spectra for the titration of a 10 μM so...
Figure 4: A) Molecular structure of 3; B) fluorescence emission spectra for the titration of a 10 μM solution...
Figure 5: A) Molecular structure of 4 and 5; B) fluorescence spectra for the titration of a 0.5 μM solution o...
Figure 6: A) Molecular structure of 6; B) possible binding mode of pyrene termini of 6 to CB[8] according to ...
Figure 7: A) Molecular structure of peptidic probes 7 and 8; B) fluorescence emission spectra of probe 7 (5.0...
Figure 8: Top: Molecular structure of 9; bottom: A) fluorescence response of 9 (500 nM) upon addition of β-tr...
Figure 9: Top: Molecular structures of 10 and 11; bottom: A) fluorescence emission spectra of 10 (1.0 µM, λex...
Figure 10: A) Structure of two peptide amphiphiles 12 and 13; B) fluorescent spectra (λex = 400 nm) from a tit...
Figure 11: a) Molecular structure of peptide 14; b) the coordinate represents the states of sensor at differen...
Beilstein J. Org. Chem. 2020, 16, 2332–2337, doi:10.3762/bjoc.16.194
Graphical Abstract
Figure 1: The molecular structure of OA (A) and Q[8] (B).
Figure 2: 1H NMR titration of OA with Q[8] were performed in D2O containing 10% DMSO by volume, OA (500 μmol·L...
Figure 3: (A) The UV–vis absorption spectra recorded for OA in the presence of Q[8] (c(Q[8]), labeled a–k: 0,...
Figure 4: IR spectra recorded for (a) Q[8], (b) OA, (c) a physical mixture of Q[8] and OA, and (d) the OA@Q[8...
Figure 5: The possible interaction mode for OA@Q[8].
Figure 6: The phase-solubility graph obtained for OA in a Q[8] aqueous solution at λ = 275 nm.
Figure 7: The clearance rate curve of ABTS+• upon increasing the concentration of OA and the OA@Q[8] inclusio...
Figure 8: The release curves of OA and OA@Q[8].
Beilstein J. Org. Chem. 2020, 16, 71–77, doi:10.3762/bjoc.16.9
Graphical Abstract
Figure 1: Chemical structures of baicalein (left), cucurbit[8]uril (right).
Figure 2: The possible interaction model for Q[8] and baicalein.
Figure 3: 1H NMR spectra (400 MHz) of Q[8] (a), baicalein (b) and BALE–Q[8] (1:1) (c) recorded in DCl.
Figure 4: The absorption spectra of BALE upon the addition of Q[8] under different conditions [10 mol·L−1 HCl...
Figure 5: IR spectra of Q[8] (a), BALE (b), a physical mixture of Q[8]-BALE (NQ[8]/NBALE = 1:1) (c) and the B...
Figure 6: DTA spectra of BALE (a), Q[8] (b), a physical mixture Q[8]-BALE (NQ[8]/NBALE = 1:1) (c) and the BAL...
Figure 7: The stability curve of UV–vis absorption obtained for an isoconcentration of BALE and the BALE–Q[8]...
Figure 8: The phase solubility graph obtained for BALE in Q[8] at λ = 270 nm.
Figure 9: The clearance rate curve (A) and clearance time curve (B) of ABTS+· upon increasing the concentrati...
Figure 10: The release curves of BALE and BALE–Q[8].
Beilstein J. Org. Chem. 2019, 15, 1913–1924, doi:10.3762/bjoc.15.187
Graphical Abstract
Figure 1: Structures of the compounds used in this study and labelling scheme for NMR spectra.
Figure 2: Spectra of complexes [1(LysOMe)2], [1(ArgOMe)2], [1(HisOMe)2]: 1H NMR (a–g) and ROESY (h–j) in meth...
Figure 3: CD (a) and UV (b) spectra of complexes [1(LysOMe)2], [1(PheOMe)2], [1(ValOMe)2], [1(ArgOMe)2], and [...
Figure 4: DOSY spectra of 1 (a), [1(LysOMe)2] (b), [1(ArgOMe)2] (c), [1(HisOMe)2] (d) and [LysOMe + 1(LysOMe)2...
Figure 5: 1H NMR spectra of 1 (a), LysOMe (b), 1H NMR and DOSY spectra of [1(LysOMe)2] (insets show the shape...
Figure 6: 1H NMR spectra of (R)-2 (a); [1((R)-2] (b); [1 + 1((R)-2] (c) (insets show the shape of signals f, ...
Figure 7: 1H NMR and DOSY spectra of (R)-2 (a); [1(R)-2] (b) (inset show the shape signals f, DMSO-d6, 298K, ...
Beilstein J. Org. Chem. 2019, 15, 1705–1711, doi:10.3762/bjoc.15.166
Graphical Abstract
Scheme 1: Chemical structures of host-1, host-2, G1, and G2.
Figure 1: 1H NMR spectra of G1 (1.0 mmol, D2O, pD = 2.0) in the presence of host-1 at different concentration...
Figure 2: 1H NMR spectra of G1 (1.0 mmol, D2O, pD = 2.0) in the presence of host-2 at different concentration...
Scheme 2: Plausible diastereomers showing the fluorescence response of G2 with host-1.
Figure 3: Fluorescence spectral changes of G2 (10.0 μM) in the presence of host-1 (a) and host-2 (b) at diffe...
Figure 4: 1H NMR spectra of G2 (1.0 mmol, D2O, pD = 2.0) in the presence of different concentrations of host-1...
Beilstein J. Org. Chem. 2018, 14, 2163–2185, doi:10.3762/bjoc.14.190
Graphical Abstract
Figure 1: The two one-electron oxidation reactions of tetrathiafulvalene (TTF, 1) and the corresponding prope...
Figure 2: UV–vis spectra and photographs of TTF 2 in its three stable oxidation states (black line = 2, orang...
Figure 3: Structure and conformations of two TTF dimers in solution, the mixed-valence and the radical-cation...
Figure 4: (a) The isomerism problem of TTF. (b)–(d) Major synthetic breakthroughs for the construction of TTF...
Figure 5: (a) Host–guest equilibrium between π-electron-poor cyclophane 3 and different TTFs with their corre...
Figure 6: TTF complexes with different host molecules.
Figure 7: Stable TTF (a) radical-cation and (b) mixed-valence dimers in confined molecular spaces.
Figure 8: A “three-pole supramolecular switch”: Controlled by its oxidation state, TTF (1) jumps back and for...
Figure 9: Redox-controlled closing and opening motion of the artificial molecular lasso 12.
Figure 10: Graphical illustration how a non-degenerate TTF-based shuttle works under electrochemical operation....
Figure 11: The first TTF-based rotaxane 13.
Figure 12: A redox-switchable bistable molecular shuttle 14.
Figure 13: The redox-switchable cyclodextrin-based rotaxane 15.
Figure 14: The redox-switchable non-ionic rotaxane 16 with a pyromellitic diimide macrocycle.
Figure 15: The redox-switchable TTF rotaxane 17 based on a crown/ammonium binding motif.
Figure 16: Structure and operation of the electro- and photochemically switchable rotaxane 18 which acts as po...
Figure 17: (a) The redox-switchable rotaxane 19 with a donor–acceptor pair which is stable in five different s...
Figure 18: Schematic representation of a molecular electronic memory based on a bistable TTF-based rotaxane. (...
Figure 19: Schematic representation of bending motion of a microcantilever beam with gold surface induced by o...
Figure 20: TTF-dimer interactions in a redox-switchable tripodal [4]rotaxane 22.
Figure 21: (a) A molecular friction clutch 23 which can be operated by electrochemical stimuli. (b) Schematic ...
Figure 22: Fusion between rotaxane and catenane: a [3]rotacatenane 24 which can stabilize TTF dimers.
Figure 23: The first TTF-based catenane 25.
Figure 24: Electrochemically controlled circumrotation of the bistable catenane 26.
Figure 25: A tristable switch based on the redox-active [2]catenane 27 with three different stations.
Figure 26: Structure of catenane-functionalized MOF NU-1000 [108] with structural representation of subcomponents. ...
Figure 27: (a) [3]Catenanes 29 and 30 which can stabilize mixed-valence or radical-cation dimers of TTF. (b) S...
Beilstein J. Org. Chem. 2015, 11, 2057–2071, doi:10.3762/bjoc.11.222
Graphical Abstract
Scheme 1: Proposed structures of complexes between 1a and 1b with 2.
Scheme 2: The formation of catenanes 6a–c.
Scheme 3: The structures of cantenanes 7a–c.
Scheme 4: The structures of dimer 8·8 and compounds 9 and 10.
Figure 1: X-ray structure of 10 showing a quadruple hydrogen-bonded dimeric motif [17].
Scheme 5: The structures of compounds 11a–g.
Figure 2: Zipper-featured folding motif of δ-peptides 11a–g driven by the cooperative donor–acceptor interact...
Scheme 6: The structures of compounds 12a–g and the formation of the helical conformation by the longer oligo...
Scheme 7: The structures of compounds 13a,b, 14, and 15a–d.
Scheme 8:
The structures of complex C60 16 and dynamic [2]catenane formed by compounds 17–19.
Scheme 9: The structure of homodimers 20a·20a and 20b·20b.
Scheme 10: The structures of foldamers 21 and 22a–c.
Scheme 11: Complexation-promoted hydrolysis of foldamer 23.
Scheme 12: The structure of foldamer 24.
Scheme 13: The structures of foldamers 24a–c.
Scheme 14: Proposed structures of heterodimers 25·28, 26·28, and 27·28.
Scheme 15: Proposed structure of complex formed by 29 and 30.
Scheme 16: The structures of polymers P31a,b and P32a–d.
Scheme 17: The structure of compound 33.
Scheme 18: The structure of compound 34.
Beilstein J. Org. Chem. 2010, 6, No. 32, doi:10.3762/bjoc.6.32
Graphical Abstract
Figure 1: Biologically important amines and quaternary ammonium salts: histamine (1), dopamine (2) and acetyl...
Figure 2: Crown ether 18-crown-6.
Figure 3: Conformations of 18-crown-6 (4) in solvents of different polarity.
Figure 4: Binding topologies of the ammonium ion depending on the crown ring size.
Figure 5: A “pseudorotaxane” structure consisting of 24-crown-8 and a secondary ammonium ion (5); R = Ph.
Figure 6: Typical examples of azacrown ethers, cryptands and related aza macrocycles.
Figure 7: Binding of ammonium to azacrown ethers and cryptands [111-113].
Figure 8: A 19-crown-6-ether with decalino blocking groups (11) and a thiazole-dibenzo-18-crown-6-ether (12).
Figure 9: 1,3-Bis(6-oxopyridazin-1-yl)propane derivatives 13 and 14 by Campayo et al.
Figure 10: Fluorescent azacrown-PET-sensors based on coumarin.
Figure 11: Two different pyridino-cryptands (17 and 18) compared to a pyridino-crown (19); chiral ammonium ion...
Figure 12: Pyridino-18-crown-6 ligand (21), a similar acridino-18-crown-6 ligand (22) and a structurally relat...
Figure 13: Ciral pyridine-azacrown ether receptors 24.
Figure 14: Chiral 15-crown-5 receptors 26 and an analogue 18-crown-6 ligand 27 derived from amino alcohols.
Figure 15: C2-symmetric chiral 18-crown-6 amino alcohol derivatives 28 and related macrocycles.
Figure 16: Macrocycles with diamide-diester groups (30).
Figure 17: C2-symmetric chiral aza-18-crown-6 ethers (31) with phenethylamine residues.
Figure 18: Chiral C-pivot p-methoxy-phenoxy-lariat ethers.
Figure 19: Chiral lariat crown ether 34.
Figure 20: Sucrose-based chiral crown ether receptors 36.
Figure 21: Permethylated fructooligosaccharide 37 showing induced-fit chiral recognition.
Figure 22: Biphenanthryl-18-crown-6 derivative 38.
Figure 23: Chiral lariat crown ethers derived from binol by Fuji et al.
Figure 24: Chiral phenolic crown ether 41 with “aryl chiral barriers” and guest amines.
Figure 25: Chiral bis-crown receptor 43 with a meso-ternaphthalene backbone.
Figure 26: Chromogenic pH-dependent bis-crown chemosensor 44 for diamines.
Figure 27: Triamine guests for binding to receptor 44.
Figure 28: Chiral bis-crown phenolphthalein chemosensors 46.
Figure 29: Crown ether amino acid 47.
Figure 30: Luminescent receptor 48 for bis-alkylammonium guests.
Figure 31: Luminescent CEAA (49a), a bis-CEAA receptor for amino acids (49b) and the structure of lysine bindi...
Figure 32: Luminescent CEAA tripeptide for binding small peptides.
Figure 33: Bis crown ether 51a self assembles co-operatively with C60-ammonium ion 51b.
Figure 34: Triptycene-based macrotricyclic dibenzo-[24]-crown-8 ether host 52 and guests.
Figure 35: Copper imido diacetic acid azacrown receptor 53a and the suggested His-Lys binding motif; a copper ...
Figure 36: Urea (54) and thiourea (55) benzo crown receptor for transport and extraction of amino acids.
Figure 37: Crown pyryliums ion receptors 56 for amino acids.
Figure 38: Ditopic sulfonamide bridged crown ether receptor 57.
Figure 39: Luminescent peptide receptor 58.
Figure 40: Luminescent receptor 59 for the detection of D-glucosamine hydrochloride in water/ethanol and lumin...
Figure 41: Guanidinium azacrown receptor 61 for simple amino acids and ditopic receptor 62 with crown ether an...
Figure 42: Chiral bicyclic guanidinium azacrown receptor 63 and similar receptor 64 for the enantioselective t...
Figure 43: Receptors for zwitterionic species based on luminescent CEAAs.
Figure 44: 1,10-Azacrown ethers with sugar podand arms and the anticancer agent busulfan.
Figure 45: Benzo-18-crown-6 modified β-cyclodextrin 69 and β-cyclodextrin functionalized with diaza-18-crown-6...
Figure 46: Receptors for colorimetric detection of primary and secondary ammonium ions.
Figure 47: Porphyrine-crown-receptors 72.
Figure 48: Porphyrin-crown ether conjugate 73 and fullerene-ammonium ion guest 74.
Figure 49: Calix[4]arene (75a), homooxocalix[4]arene (75b) and resorcin[4]arene (75c) compared (R = H, alkyl c...
Figure 50: Calix[4]arene and ammonium ion guest (R = H, alkyl, OAcyl etc.), possible binding sites; A: co-ordi...
Figure 51: Typical guests for studies with calixarenes and related molecules.
Figure 52: Lower rim modified p-tert-butylcalix[5]arenes 82.
Figure 53: The first example of a water soluble calixarene.
Figure 54: Sulfonated water soluble calix[n]arenes that bind ammonium ions.
Figure 55: Displacement assay for acetylcholine (3) with a sulfonato-calix[6]arene (84b).
Figure 56: Amino acid inclusion in p-sulfonatocalix[4]arene (84a).
Figure 57: Calixarene receptor family 86 with upper and lower rim functionalization.
Figure 58: Calix[6]arenes 87 with one carboxylic acid functionality.
Figure 59: Sulfonated calix[n]arenes with mono-substitution at the lower rim systematically studied on their r...
Figure 60: Cyclotetrachromotropylene host (91) and its binding to lysine (81c).
Figure 61: Calixarenes 92 and 93 with phosphonic acids groups.
Figure 62: Calix[4]arene tetraphosphonic acid (94a) and a double bridged analogue (94b).
Figure 63: Calix[4]arene tetraphosphonic acid ester (92c) for surface recognition experiments.
Figure 64: Calixarene receptors 95 with α-aminophosphonate groups.
Figure 65: A bridged homocalix[3]arene 95 and a distally bridged homocalix[4]crown 96.
Figure 66: Homocalix[3]arene ammonium ion receptor 97a and the Reichardt’s dye (97b) for colorimetric assays.
Figure 67: Chromogenic diazo-bridged calix[4]arene 98.
Figure 68: Calixarene receptor 99 by Huang et al.
Figure 69: Calixarenes 100 reported by Parisi et al.
Figure 70: Guest molecules for inclusion in calixarenes 100: DAP × 2 HCl (101a), APA (101b) and Lys-OMe × 2 HC...
Figure 71: Different N-linked peptido-calixarenes open and with glycol chain bridges.
Figure 72: (S)-1,1′-Bi-2-naphthol calixarene derivative 104 published by Kubo et al.
Figure 73: A chiral ammonium-ion receptor 105 based on the calix[4]arene skeleton.
Figure 74: R-/S-phenylalaninol functionalized calix[6]arenes 106a and 106b.
Figure 75: Capped homocalix[3]arene ammonium ion receptor 107.
Figure 76: Two C3 symmetric capped calix[6]arenes 108 and 109.
Figure 77: Phosphorous-containing rigidified calix[6]arene 110.
Figure 78: Calix[6]azacryptand 111.
Figure 79: Further substituted calix[6]azacryptands 112.
Figure 80: Resorcin[4]arene (75c) and the cavitands (113).
Figure 81: Tetrasulfonatomethylcalix[4]resorcinarene (114).
Figure 82: Resorcin[4]arenes (115a/b) and pyrogallo[4]arenes (115c, 116).
Figure 83: Displacement assay for acetylcholine (3) with tetracyanoresorcin[4]arene (117).
Figure 84: Tetramethoxy resorcinarene mono-crown-5 (118).
Figure 85: Components of a resorcinarene based displacement assay for ammonium ions.
Figure 86: Chiral basket resorcin[4]arenas 121.
Figure 87: Resorcinarenes with deeper cavitand structure (122).
Figure 88: Resorcinarene with partially open deeper cavitand structure (123).
Figure 89: Water-stabilized deep cavitands with partially structure (124, 125).
Figure 90: Charged cavitands 126 for tetralkylammonium ions.
Figure 91: Ditopic calix[4]arene receptor 127 capped with glycol chains.
Figure 92: A calix[5]arene dimer for diammonium salt recognition.
Figure 93: Calixarene parts 92c and 129 for the formation molecular capsules.
Figure 94: Encapsulation of a quaternary ammonium cation by two resorcin[4]arene molecules (NMe4+@[75c]2 × Cl−...
Figure 95: Encapsulation of a quaternary ammonium cation by six resorcin[4]arene molecules (NMe3D+@[130]6 × Cl−...
Figure 96: Structure and schematic of cucurbit[6]uril (CB[6], 131a).
Figure 97: Cyclohexanocucurbit[6]uril (CB′[6], 132) and the guest molecule spermine (133).
Figure 98: α,α,δ,δ-Tetramethylcucurbit[6]uril (134).
Figure 99: Structure of the cucurbituril-phthalhydrazide analogue 135.
Figure 100: Organic cavities for the displacement assay for amine differentiation.
Figure 101: Displacement assay methodology for diammonium- and related guests involving cucurbiturils and some ...
Figure 102: Nor-seco-Cucurbituril (±)-bis-ns-CB[6] (140) and guest molecules.
Figure 103: The cucurbit[6]uril based complexes 141 for chiral discrimination.
Figure 104: Cucurbit[7]uril (131c) and its ferrocene guests (142) opposed.
Figure 105: Cucurbit[7]uril (131c) guest inclusion and representative guests.
Figure 106: Cucurbit[7]uril (131c) binding to succinylcholine (145) and different bis-ammonium and bis-phosphon...
Figure 107: Paraquat-cucurbit[8]uril complex 149.
Figure 108: Gluconuril-based ammonium receptors 150.
Figure 109: Examples of clefts (151a), tweezers (151b, 151c, 151d) and clips (151e).
Figure 110: Kemp’s triacid (152a), on example of Rebek’s receptors (152b) and guests.
Figure 111: Amino acid receptor (154) by Rebek et al.
Figure 112: Hexagonal lattice designed hosts by Bell et al.
Figure 113: Bell’s amidinium receptor (156) and the amidinium ion (157).
Figure 114: Aromatic phosphonic acids.
Figure 115: Xylene phosphonates 159 and 160a/b for recognition of amines and amino alcohols.
Figure 116: Bisphosphonate recognition motif 161 for a colorimetric assay with alizarin complexone (163) for ca...
Figure 117: Bisphosphonate/phosphate clip 164 and bisphosphonate cleft 165.
Figure 118: N-Methylpyrazine 166a, N-methylnicotinamide iodide (166b) and NAD+ (166c).
Figure 119: Bisphosphate cavitands.
Figure 120: Bisphosphonate 167 of Schrader and Finocchiaro.
Figure 121: Tweezer 168 for noradrenaline (80b).
Figure 122: Different tripods and heparin (170).
Figure 123: Squaramide based receptors 172.
Figure 124: Cage like NH4+ receptor 173 of Kim et al.
Figure 125: Ammonium receptors 174 of Chin et al.
Figure 126: 2-Oxazolin-based ammonium receptors 175a–d and 176 by Ahn et al.
Figure 127: Racemic guest molecules 177.
Figure 128: Tripods based on a imidazole containing macrocycle (178) and the guest molecules employed in the st...
Figure 129: Ammonium ion receptor 180.
Figure 130: Tetraoxa[3.3.3.3]paracyclophanes 181 and a cyclophanic tetraester (182).
Figure 131: Peptidic bridged paraquat-cyclophane.
Figure 132: Shape-selective noradrenaline host.
Figure 133: Receptor 185 for binding of noradrenaline on surface layers from Schrader et al.
Figure 134: Tetraphosphonate receptor for binding of noradrenaline.
Figure 135: Tetraphosphonate 187 of Schrader and Finocchiaro.
Figure 136: Zinc-Porphyrin ammonium-ion receptors 188 and 189 of Mizutani et al.
Figure 137: Zinc porphyrin receptor 190.
Figure 138: Zinc porphyrin receptors 191 capable of amino acid binding.
Figure 139: Zinc-porphyrins with amino acid side chains for stereoinduction.
Figure 140: Bis-zinc-bis-porphyrin based on Tröger’s base 193.
Figure 141: BINAP-zinc-prophyrin derivative 194 and it’s guests.
Figure 142: Bisaryl-linked-zinc-porphyrin receptors.
Figure 143: Bis-zinc-porphyrin 199 for diamine recognition and guests.
Figure 144: Bis-zinc-porphyrin crown ether 201.
Figure 145: Bis-zinc-porphyrin 202 for stereodiscrimination (L = large substituent; S = small substituent).
Figure 146: Bis-zinc-porphyrin[3]rotaxane and its copper complex and guests.
Figure 147: Dien-bipyridyl ligand 206 for co-ordination of two metal atoms.
Figure 148: The ligand and corresponding tetradentate co-complex 207 serving as enantioselective receptor for a...
Figure 149: Bis(oxazoline)–copper(II) complex 208 for the recognition of amino acids in aqueous solution.
Figure 150: Zinc-salen-complexes 209 for the recognition tertiary amines.
Figure 151: Bis(oxazoline)–copper(II) 211 for the recognition of amino acids in aqueous solution.
Figure 152: Zn(II)-complex of a C2 terpyridine crown ether.
Figure 153: Displacement assay and receptor for aspartate over glutamate.
Figure 154: Chiral complex 214 for a colorimetric displacement assay for amino acids.
Figure 155: Metal complex receptor 215 with tripeptide side arms.
Figure 156: A sandwich complex 216 and its displaceable dye 217.
Figure 157: Lanthanide complexes 218–220 for amino acid recognition.
Figure 158: Nonactin (221), valinomycin (222) and vancomycin (223).
Figure 159: Monesin (224a) and a chiral analogue for enantiodiscrimination of ammonium guests (224b).
Figure 160: Chiral podands (226) compared to pentaglyme-dimethylether (225) and 18-crown-6 (4).
Figure 161: Lasalocid A (228).
Figure 162: Lasalocid derivatives (230) of Sessler et al.
Figure 163: The Coporphyrin I tetraanion (231).
Figure 164: Linear and cyclic peptides for ammonium ion recognition.
Figure 165: Cyclic and bicyclic depsipeptides for ammonium ion recognition.
Figure 166: α-Cyclodextrin (136a) and novocaine (236).
Figure 167: Helical diol receptor 237 by Reetz and Sostmann.
Figure 168: Ammonium binding spherand by Cram et al. (238a) and the cyclic[6]metaphenylacetylene 238b in compar...
Figure 169: Receptor for peptide backbone and ammonium binding (239).
Figure 170: Anion sensor principle with 3-hydroxy-2-naphthanilide of Jiang et al.
Figure 171: 7-bromo-3-hydroxy-N-(2-hydroxyphenyl)naphthalene 2-carboxamide (241) and its amine binding.
Figure 172: Naturally occurring catechins with affinity to quaternary ammonium ions.
Figure 173: Spiropyran (244) and merocyanine form (244a) of the amino acid receptors of Fuji et al.
Figure 174: Coumarin aldehyde (245) and its iminium species with amino acid bound (245a) by Glass et al.
Figure 175: Coumarin aldehyde appended with boronic acid.
Figure 176: Quinolone aldehyde dimers by Glass et al.
Figure 177: Chromogenic ammonium ion receptors with trifluoroacetophenone recognition motifs.
Figure 178: Chromogenic ammonium ion receptor with trifluoroacetophenone recognition motif bound on different m...